Time- and dose-dependent effect of fosfomycin on suppression of infection-induced endotoxin shock in mice

Biological and Pharmaceutical Bulletin

Volumn 25, Issue 12, 2002, Pages 1658-1661

  Kawaguchi, Kiichiro ^a   Hasunuma, Ryoichi ^a   Kikuchi, Sei Ichi ^a   Ryll, Roland ^a   Morikawa, Keiko ^b   Kumazawa, Yoshio ^a  

^a KITASATO UNIVERSITY   (Japan)

^b SAGAMI WOMEN'S UNIVERSITY   (Japan)

Author keywords

Endotoxin shock; Fosfomycin; Imipenem; Salmonella infection

Indexed keywords

ANTIBIOTIC AGENT; BACTERIUM LIPOPOLYSACCHARIDE; FIBRINOGEN; FOSFOMYCIN; IMIPENEM;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIMICROBIAL ACTIVITY; ARTICLE; BACTERIAL COUNT; COLONY FORMING UNIT; CONTROLLED STUDY; DOSE RESPONSE; DOSE TIME EFFECT RELATION; DRUG EFFECT; DRUG EFFICACY; ENANTIOMER; INFECTION; LIVER; MOUSE; NONHUMAN; PROTHROMBIN TIME; SALMONELLA TYPHI; SEPTIC SHOCK; SPLEEN; ANIMAL; ANIMAL SALMONELLOSIS; BAGG ALBINO MOUSE; BLOOD; COMPARATIVE STUDY; FEMALE; SALMONELLA TYPHIMURIUM; TIME;

ANIMALS; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; FOSFOMYCIN; MICE; MICE, INBRED BALB C; SALMONELLA INFECTIONS, ANIMAL; SALMONELLA TYPHIMURIUM; SHOCK, SEPTIC; TIME FACTORS;

EID: 1242282180     PISSN: 09186158     EISSN: None     Source Type: Journal    
DOI: 10.1248/bpb.25.1658     Document Type: Article

References (21)

1. Karima R., Matsumoto S., Higashi H., Matsushima K., Mol Med. Today, 5, 123-132 (1999).
2. Aderem A., Ulevitch R. J., Nature (London), 406, 782-787 (2000).
3. O'Reilly M., Newcomb D. E., Remick D., Shock, 12, 411-420 (1999).
4. Galanos C., Freudenberg M. A., Reutter W., Proc Natl. Acad. Sci. U S A., 76, 5939-5943 (1979).
5. Freudenberg M. A., Keppler D., Galanos C., Infect. Immun., 51, 891-895 (1986).
6. Lehmann V., Freudenberg M. A., Galanos C., J. Exp. Med., 165, 657-663 (1987).
7. Bucklin S. E., Morrison D. C., J Infect Dis., 172, 1519-1527 (1995).
8. Neu H. C., Am J. Med., 79, 2-13 (1985).
9. Jackson J. J , Kropp H , J Infect. Dis., 165, 1033-1044 (1992).
10. Kahan F. M., Kahan J. S., Cassidy P J , Kropp B., Ann. N. Y. Acad. Sci., 235, 364-386 (1974).
11. Morikawa K., Watabe H., Araake M., Morikawa S., Antimicrob Agents Chemother., 40, 1366-1370 (1996).
12. Matsumoto T., Tateda K., Miyazaki S., Furuya N., Ohno A., Ishii Y., Hirakata Y., Yamaguchi K., Antimicrob. Agents Chemother., 41, 308-313 (1997).
13. Takakuwa T., Knopf H. P , Sing A., Carsetti R., Galanos C., Freudenberg M. A., Eur. J. Immunol., 26, 2686-2692 (1996).
14. Morita H., Hasunuma R., Fujihara M., Tanaka S., Galanos C., Freudenberg M. A., Morrison D. C., Kumazawa Y., J. Endotoxin Res., 4, 339-346 (1997).
15. Matsumoto T., Tateda K., Miyazaki S., Furuya N., Ohno A., Ishii Y , Hirakata Y , Yamaguchi K., Antimicrob. Agents Chemother., 43, 697-698 (1999).
16. Eng R. H., Smith S. M., Fan-Havard P., Ogbara T., Diagn. Microbiol. Infect. Dis., 16, 185-189 (1993).
17. Prins J. M., van Agtmael M. A., Kuijper E J., van Deventer S. J., Speelman P., J Infect Dis., 172, 886-891 (1995).
18. Luchi M., Morrison D. C., Opal S., Yoneda K., Slotman G., Chambers H., Wiesenfeld H , Lemke J., Ryan J. L , Horn D., J. Endotoxin Res , 6, 25-31 (2000).
19. Thijs L. G., de Boer J. P , de Groot M. C., Hack C. E., Intensive Care Med., 19 (Suppl 1), S8-15 (1993).
20. Emerson T. E , Fournel M. A, Leach W. J., Redens T. B., Circ. Shock, 21, 1-13 (1987).
21. Giacometti A., Cirioni O., Ghiselli R., Viticchi C., Mocchegiani F., Riva A., Saba V., Scalise G., Crit. Care Med., 29, 1666-1669 (2001).